纳米传感器
蛋白酵素
蛋白酶
肽
癌症研究
劈理(地质)
化学
生物
酶
生物化学
纳米技术
材料科学
断裂(地质)
古生物学
作者
Ester J. Kwon,Jaideep S. Dudani,Sangeeta N. Bhatia
标识
DOI:10.1038/s41551-017-0054
摘要
The ability to identify cancer lesions with endogenous biomarkers is currently limited to tumours ~1 cm in diameter. We recently reported an exogenously administered tumour-penetrating nanosensor that sheds, in response to tumour-specific proteases, peptide fragments that can then be detected in the urine. Here, we report the optimization, informed by a pharmacokinetic mathematical model, of the surface presentation of the peptide substrates to both enhance on-target protease cleavage and minimize off-target cleavage, and of the functionalization of the nanosensors with tumour-penetrating ligands that engage active trafficking pathways to increase activation in the tumour microenvironment. The resulting nanosensor discriminated sub-5 mm lesions in human epithelial tumours and detected nodules with median diameters smaller than 2 mm in an orthotopic model of ovarian cancer. We also demonstrate enhanced receptor-dependent specificity of signal generation in the urine in an immunocompetent model of colorectal liver metastases, and in situ activation of the nanosensors in human tumour microarrays when re-engineered as fluorogenic zymography probes.
科研通智能强力驱动
Strongly Powered by AbleSci AI